Author:
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 668 | 365 | 16 |
| Full Text Views | 10 | 1 | 0 |
| PDF Downloads | 12 | 0 | 0 |
Single Dose Therapy of Paragonimiasis with Menichlopholan
Chukuedu Nwokolo
Chukuedu Nwokolo
University of Nigeria, Enugu Campus, Bernhard-Nocht-Institut für Schiffs- und Tropenkrankheiten, Hamburg, Nigeria
Search for other papers by Chukuedu Nwokolo in
Current site
Google Scholar
PubMed
Search for other papers by Chukuedu Nwokolo in
Current site
Google Scholar
PubMed
Klaus J. Volkmer
Klaus J. Volkmer
University of Nigeria, Enugu Campus, Bernhard-Nocht-Institut für Schiffs- und Tropenkrankheiten, Hamburg, Nigeria
Search for other papers by Klaus J. Volkmer in
Current site
Google Scholar
PubMed
Search for other papers by Klaus J. Volkmer in
Current site
Google Scholar
PubMed
Menichlopholan, a biphenyl compound, in a single dose of 2 mg/kg body weight, gave a 73%–90% cure rate in the treatment of pulmonary infections due to Paragonimus uterobilateralis at two centers in Nigeria. Ninety-five patients were followed up for 4 months, and 58 for 1 year. Side effects of the drug included sweating and body pains, but there was no significant biochemical or hematological evidence of damage to the internal organs. The advantages of single dose therapy are likely to make menichlopholan the treatment of choice for paragonimiasis in Africa, and probably elsewhere.
Author Notes
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 668 | 365 | 16 |
| Full Text Views | 10 | 1 | 0 |
| PDF Downloads | 12 | 0 | 0 |